Navigation Links
Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results
Date:2/18/2009

any's preliminary studies and preclinical research; competition and the timing of projects and trends in future operating performance, the Company's ability to meet its funding milestones under its financing transaction, the Company's ability to comply with the continued listing standards of the AMEX, as well as other factors expressed from time to time in the Company's periodic filings with the Securities and Exchange Commission (the "SEC"). As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are made only as of the date of this press release, and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

    Company Contact:                            Investor Relations Contact:
    Senesco Technologies, Inc.                  FD
    Joel Brooks                                 Brian Ritchie
    Chief Financial Officer                     brian.ritchie@fd.com
    jbrooks@senesco.com                         212-850-5600
     

                      SENESCO TECHNOLOGIES, INC. AND SUBSIDIARY
                            (A DEVELOPMENT STAGE COMPANY)
                   CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                     (unaudited)

                                    For the Three   For the Three
                                     Months Ended    Months Ended
                                     December 31,    December 31,
                                         2008            2007

    Revenue                                 $--         $6,250

    Operating Expenses:

      General and administrative        649,056        585,851
      Research and development          579,286        392
'/>"/>
SOURCE Senesco Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Senesco and Harris Moran Mutually Agree to Terminate Development and License Agreement Due to Restructuring
2. Senesco Appoints Harlan W. Waksal, M.D., to Board of Directors
3. Senescos Preclinical Multiple Myeloma Data to be Presented at the 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
4. Senesco Technologies Announces Successful Completion of First Milestone Related to Agreement with Bayer CropScience
5. Senesco Technologies Closes Remaining $3.0 Million of Previously Announced Financing
6. Senesco Signs a Supply Agreement for Polyplus-transfections Delivery System
7. Senesco Technologies to Present at BIO 2008 Business Forum
8. Senesco Technologies Reports Third Quarter Fiscal 2008 Financial Results
9. Senesco Technologies Regains Compliance With Amexs Continued Listing Requirements
10. Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results
11. Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013 A new look at “big ... other trends will highlight technical sessions at SPIE ... In its 33rd year, the three-day event is the ... key suppliers, approximately 100 technical presentations and numerous networking ... society for optics and photonics , the meeting will ...
(Date:6/18/2013)... Cord Blood Corporation (NYSE: CO ) ("CCBC" ... collection, laboratory testing, hematopoietic stem cell processing, and stem ... results for the fourth quarter and full year of ... Fourth Quarter of Fiscal 2013 Highlights , ... by 33.3% to RMB133.0 million ($21.4 million) from RMB99.8 ...
(Date:6/18/2013)... Miami, FL (PRWEB) June 18, 2013 The ... associate the skin as an important human body part. Similar ... cared for in order to function, repair and grow. Recent ... with vitamins and supplements, is just as important as other ... and supplements to aid in skin cell reproduction, increase the ...
(Date:6/18/2013)... June 18, 2013  regulated information — Global biopharmaceutical ... today announced the launch of a new Pledge ... The Pledge empowers the millions ... and make a personal commitment to demand more: greater ... care team and additional partial-onset seizure control.  More information ...
Breaking Biology Technology:‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 3China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 2China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 3China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 4China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 5China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 6China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 7China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 8China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 9China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 10China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 11China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 12China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 13Natural Acne Remedies Through Diet, Probiotic Action Shares New Insight on What Foods May Help Lead to Clear Skin 2Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 2Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 3Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 4Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 5Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy 6
... 18, 2012 On the 23-25 May, The ... 65-strong consortium of C-level executives and operational officers from the ... annual Next Generation Healthcare Summit. Positioned at the very pinnacle ... trend as the most well respected event for the Healthcare ...
... 17, 2012  ETEX Corporation, an advanced biomaterials company, ... Technology Community 8th Stem Cell Summit, April 19-20, ... MA. ETEX will highlight their cell carrier development ... & Partnering as well as Stem Cell Research ...
... Senior clinical executives from top pharmaceutical companies, including ... the US offices of Shire Pharmaceuticals to agree ... competition to recognise and encourage talented researchers in ... Clinical Researcher of the Year competition ( http://www.usclinicalresearcher.com ...
Cached Biology Technology:GDS International Combines Top Healthcare Executives in the United States for its 10th Anniversary NG Healthcare Summit in May 2GDS International Combines Top Healthcare Executives in the United States for its 10th Anniversary NG Healthcare Summit in May 3ETEX Corporation to Present at GTC Stem Cell Summit 2Quality Standards Established for Competition to Identify Best Researchers in the US 2
(Date:6/18/2013)... of Calgary,s Faculty of Medicine have discovered a mechanism ... bacteria. Platelets, a component of blood typically associated with ... and upon detection, seal it off from the rest ... Nature Immunology this week, provide the science ... science community has known that platelets do participate in ...
(Date:6/18/2013)... Research Council, Laboratory of Molecular Biology, has been ... Young Investigator Award. Torrent is being recognized for ... algorithm to predict antimicrobial regions in proteins. Luis ... now applying this algorithm to interrogate full genomes ... with very appealing results." , Torrent obtained ...
(Date:6/18/2013)... 10% of breast and ovarian cancers are familial in ... attributable to inherited mutations from the parents in genes ... mutations, PARP inhibitors, which are currently in clinical trials, ... option for personalised cancer treatment, an alternative to standard ... of these patients generate resistance to the drug and, ...
Breaking Biology News(10 mins):Immunity mechanism discovered 2The American Society for Microbiology honors Marc Torrent 2An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2
... HARBOR, N.Y. (Jan. 4, 2011) -- Imaging technologies ... now essential tools for researchers in the field. ... Biology , presents a comprehensive set of visualization methods ... volume in a series of imaging manuals published by ...
... hair follicle progenitors Androgenetic alopecia (AGA) is a ... However, it is more common in men, in whom it ... bald and non-bald scalp samples from men with AGA, a ... of Pennsylvania School of Medicine, Philadelphia, has gained new insight ...
... CAMBRIDGE, Mass. -- About one-third of the human population ... but most of them don,t know it. Though ... be harmful to individuals with suppressed immune systems, and to ... spores are found in dirt and easily infect farm animals ...
Cached Biology News:Developmental biology is focus of new volume in laboratory manual series on imaging 2JCI online early table of contents: Jan. 4, 2011 2JCI online early table of contents: Jan. 4, 2011 3JCI online early table of contents: Jan. 4, 2011 4JCI online early table of contents: Jan. 4, 2011 5JCI online early table of contents: Jan. 4, 2011 6MIT researchers study the danger of toxoplasma parasites 2
Glucagon-like peptide-1 (GLP-1 (1-36) amide)...
... Molecule Localization in Early Drug Development with ... Get essential drug compound localization data in ... Discoverys imaging mass spectrometry service maps ... histological images so you can localize drugs ...
Best pricing for 100mg-1.0g scales. Phosphopeptides are our specialty....
... The ProteomeLab PF 2D is an ... of complex protein mixtures. Part of ... PF 2D produces results in just hours. ... of proteins present in cell lysates, addressing ...
Biology Products: